Lensar has announced global healthcare senior executive Gary Winer has joined the company’s board of directors, effective immediately.
“Lensar’s impressive growth in the global market will be well served by Gary’s significant international experience and we look forward to his insights to build on our momentum,” Nicholas Curtis, CEO of Lensar, said in a company news release. “The refractive cataract market is poised for explosive growth and working with Gary and the rest of the board we can continue to leverage the opportunities for our technology and surgeons.”
With more than 20 years in leadership positions in the healthcare and pharmaceutical industries, Mr. Winer has been tapped by Fortune 100 companies to manage blockbuster product lines and introductions in the United States, Latin America, Asia, and Japan. Notably, Mr. Winer has contributed his leadership and market skills to companies including AbbVie, Abbott Laboratories, and Pfizer, helping launch and promote such notable brands as Humira and Celebrex.
“I have long admired Lensar’s differentiation, both in terms of technology and business approach,” said Mr. Winer. “The refractive cataract market is very dynamic and the challenge of managing and sustaining growth for Lensar is incredibly appealing.”